Two Years of Experience with Abiraterone in Patients with Castration-Resistant Prostate Cancer - Indications before Chemotherapy
dc.contributor.author | Richter Igor | cs |
dc.contributor.author | Dvořák Josef | cs |
dc.contributor.author | Bartoš Jiří | cs |
dc.date.accessioned | 2020-06-08T09:42:41Z | |
dc.date.available | 10-12-2019 | en |
dc.date.available | 2020-06-08T09:42:41Z | |
dc.date.issued | 2018 | cs |
dc.date.updated | 29-06-2019 | en |
dc.format.extent | 0 | cs |
dc.identifier.uri | https://dspace.tul.cz/handle/15240/155918 | |
dc.language.iso | cze | cs |
dc.relation.ispartofseries | 0 | cs |
dc.subject | Castration-Resistant Prostate Cancer | cs |
dc.title | Two Years of Experience with Abiraterone in Patients with Castration-Resistant Prostate Cancer - Indications before Chemotherapy | en |
dc.title | Dvouletá zkušenost s abirateronem u pacientů s kastračně-rezistentním karcinomem prostaty 8211 indikace před podáním chemoterapie | cs |
local.identifier.publikace | 6550 |